GLP-1 stands for glucagon-like peptide-1, a naturally occurring hormone involved in blood sugar regulation, insulin response, digestion, and appetite control. GLP-1 medications are designed to mimic this hormone, helping the body feel fuller longer while slowing gastric emptying and reducing hunger signals in the brain. These medications were originally developed to help manage type 2 diabetes, but they are now widely used as part of medically supervised weight management programs.
The GLP-1 treatment has become increasingly popular because it addresses biological factors that can make weight loss difficult. Rather than relying solely on willpower, these medications help regulate appetite and improve metabolic function. At Eden Health Club, treatment plans are individualized and often paired with lifestyle guidance, nutrition support, and wellness coaching to help encourage healthier long-term habits.
Semaglutide
Semaglutide is one of the most widely recognized GLP-1 medications used for medical weight management. It works by activating GLP-1 receptors that help regulate appetite, blood sugar levels, and feelings of fullness after eating. Many individuals notice they feel satisfied with smaller portions and experience fewer cravings throughout the day.
Semaglutide is typically administered as a once-weekly injection and is gradually adjusted over time based on your response and tolerance. Because digestion slows slightly while using the medication, food remains in the stomach longer, which contributes to reduced hunger. Many people pursuing GLP-1 treatment choose semaglutide as part of a comprehensive wellness strategy focused on sustainable lifestyle changes rather than quick fixes.
Tirzepatide (Mounjaro®)
Tirzepatide is an advanced injectable medication that works by activating both GLP-1 and glucose-dependent insulinotropic polypeptide (GIP) receptors. This dual-action mechanism may help regulate appetite, improve insulin sensitivity, support portion control, and encourage gradual, medically supervised weight loss.
Many individuals recognize tirzepatide under the brand name Mounjaro®, which was originally developed for the treatment of type 2 diabetes. Because it targets multiple metabolic pathways, some patients experience significant improvements in hunger control and eating behaviors while maintaining the convenience of a once-weekly injection schedule.
Treatment plans are customized based on individual goals, health history, and response to therapy. At Eden Health Club, tirzepatide treatment is paired with ongoing monitoring, wellness guidance, and regular follow-up appointments to help support safe, sustainable progress.